Medipharm Labs Corp T.LABS

Alternate Symbol(s): MEDIF

Healthcare Cannabis

MediPharm Labs Corp. is a Canada-based full-service pharmaceutical company. The Company specializes in the development and manufacture of purified, pharmaceutical-quality cannabis concentrates, active pharmaceutical ingredients (API) and advanced derivative products. Through its wholesale and white label platforms, the Company formulates, develops (including through sensory testing), processes, packages and distributes cannabis extracts and advanced cannabinoid-based products to domestic and international markets. It also provides GMP flower sourcing, packaging, and distribution services for select international clients. In addition, it cultivates cannabis to sell as dried flower, pre-roll and other cannabis products for the adult use and medical markets. It also sells metered dose inhalers and aerosol sublingual sprays. Through Harvest Medicine, it provides clinic services to Canadian patients requiring medical cannabis education and prescriptions.

TSX:LABS - Post by User

Medipharm Labs Corp > Seems frothy

<< Previous

Bullboard Posts

Next >>

Comment by QContinuum1on Nov 13, 2024 7:35am

85 Views

Post# 36309787

RE:RE:Seems frothy

If a 400M Euro medical market in Germany isn't enough for Medipharm or it's numerous partners in Germany (one being a massive one), then I don't know how much would be enough.

There is no excuse for Medipharm to not be achieving $10M CDN alone from Germany. None.

<< Previous

Bullboard Posts

Next >>

Visionstate set to leverage success in the U.S. market